Aldeyra Therapeutics, Inc. (ALDX) Deep Dive Video

Name: Aldeyra Therapeutics, Inc. (ALDX) Deep Dive Video | Flash
Uploaded: 2026-03-05T17:09:16.371
Description: ALDX is a single-drug, March-2026 FDA coin-flip: approval unlocks AbbVie-led commercialization and $200M milestones; rejection risks a dilution-driven reset to cash value.

Summary

ALDX is a single-drug, March-2026 FDA coin-flip: approval unlocks AbbVie-led commercialization and $200M milestones; rejection risks a dilution-driven reset to cash value.

View ALDX stock page · Read the ALDX research report

Loading the video player…